Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Innovations in Percutaneous Transluminal Coronary Angioplasty and Transcatheter Aortic Valves

VIEWS: 14 PAGES: 4

This report covers innovations across the percutaneous transluminal coronary angioplasty and transcatheter aortic valve spaces. Innovations in both devices and techniques are reviewed. Devices covered include drug eluting stents, drug coated balloons, embolic protection devices and trascatheter valves.

More Info
									Innovations in Percutaneous Transluminal Coronary Angioplasty and Transcatheter
Aortic Valves

Published:November 2011
No.Of Pages:70
Price:US $ 3835




Report Summary

This report covers innovations across the percutaneous transluminal coronary angioplasty and
transcatheter aortic valve spaces. Innovations in both devices and techniques are reviewed.
Devices covered include drug eluting stents, drug coated balloons, embolic protection devices
and trascatheter valves. The report also examines the regulatory status of products under
investigation.

Features and benefits

* Assess the markets for percutaneous transluminal coronary angioplasty devices and
transcatheter valves.
* Forecast epidemiology of key cardiology indications which impact the Percutaneous
Transluminal Coronary Angioplasty and transcatheter aortic valve markets.
* Evaluate innovations in percutaneous transluminal coronary angioplasty devices.
* Analyze how percutaneous transluminal coronary angioplasty techniques are changing.
* Gain an understanding of the leading transcatheter aortic valves which are under investigation
for approval.

Highlights

The global market for percutaneous transluminal angioplasty is valued at $9.1bn in 2010, and is
set to grow at a CAGR of 13.8% to reach $19.1bn in 2016. The market is being driven by the rise
in procedural volumes with an increase in the average age of the population in the US and Japan,
and the increase in the penetration of PCI in Asia.

Future directions in the DES space focus on inventing DES that are safer (lower risk of
thrombosis), more maneuverable in order to treat dispersed lesions, and have novel therapeutic
properties, such as self-expandable DES, bifurcation stents and DES with more than one drug
offering.

New imaging techniques are the main area in transcatheter aortic valves innovation. Edwards
Lifesciences Sapien valve became the first product to be approved in the US.
Table Of Contents

About the author
Disclaimer

EXECUTIVE SUMMARY
Overview of percutaneous transluminal coronary angioplasty
Innovations in PTCA products
Innovations in PTCA techniques
Innovations in transcatheter aortic valves

Overview of percutaneous transluminal coronary angioplasty
Summary
Introduction
Epidemiology of cardiovascular diseases
Introduction to PTCA
PTCA procedure
Market size and forecasts for PTCA
Historical market size and forecasts

Innovations in PTCA products
Summary
Introduction
Innovations
Balloon catheters
Drug-eluting stents
Drug-eluting balloons
Embolic protection devices
Vascular access closure devices

Innovations in PTCA techniques
Summary
Introduction
Innovations
Intravascular ultrasonography
Coronary physiologic assessment
Hybrid coronary intervention
Adjunct PTCA therapies
Anti-coagulants used in PTCA

Innovations in transcatheter aortic valves
Summary
Introduction
Etiology of valve disease
Introduction to TAVI
Implantation technique
Market opportunities in TAVs
Innovations in TAV
Sapien valve
CoreValve prosthesis
Other investigational devices
Leading trancatheter aortic valve manufacturers

Appendix
Scope
Methodology
Glossary/Abbreviations
Bibliography/References

List Of Tables

Table: Epidemiology of major cardiovascular diseases, 2010
Table: Forecast epidemiology of dyslipidemia across the 7MM, 2010–16
Table: Forecast epidemiology of stroke across the 7MM, 2010–16
Table: Leading players in the global drug-coated balloon market
Table: Developmental stages of selected drug-coated balloon devices
Table: Standard derived IVUS measurements
Table: Leading TAV manufacturers
Table: Leading TAV manufacturers (contd.)

List Of Figures

Figure: Rotational atherectomy catheter
Figure: Global Percutaneous Transluminal Coronary Angioplasty Market ($bn), 2010–16
Figure: Potential market size for various applications of DCBs in the US, 2012
Figure: Proximal occlusion device
Figure: Fibernet device mounted on a guidewire
Figure: Fibernet filter in the arterial vessel wall
Figure: Vascular access closure device
Figure: Normal coronary artery structure on IVUS
Figure: Fractional flow reserve measurement using Intracoronary physiologic assessment
Figure: Ishimaru classification of the thoracic aortic landing zones
Figure: Normal aortic valve vs. bicuspid aortic valve
Figure: Mechanical valve
Figure: Tissue valve
Figure: Transcatheter heart valve
Figure: Transfemoral aortic valve implantation
Figure: Transapical aortic valve implantation
About Us:

ReportsnReports is an online library of over 100,000+ market research reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:

Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit our Market Research Blog

								
To top